Exhibit 107
CALCULATION OF FILING FEE TABLE
424(b)(5)
(Form Type)
Chinook Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Title of Each Class of to be Registered |
Fee Calculation Rule |
Amount to Registered(1) |
Proposed Offering Share |
Maximum Aggregate Price |
Fee Rate |
Amount of Registration Fee(2) | |||||||||
| Fees to be Paid |
Equity | Common stock, par value $0.0001 per share | Rule 457(c) and Rule 457(r) |
— | — | $150,000,000 | $0.00011020 | $16,530 | ||||||||
| Fees Previously Paid |
— | — | — | — | — | — | — | — | ||||||||
| Total Offering Amounts | — | $150,000,000 | — | $16,530 | ||||||||||||
| Total Fees Previously Paid | — | — | — | |||||||||||||
| Total Fee Offsets | — | — | — | $— | ||||||||||||
| Net Fee Due | — | — | — | $16,530 | ||||||||||||
| (1) | Consists of shares to be issued pursuant to that certain Sales Agreement dated April 7, 2021 (as amended by Amendment No. 1 dated November 10, 2022), by and among the Company, SVB Securities LLC (previously known as SVB Leerink LLC) and Cantor Fitzgerald & Co. |
| (2) | Calculated in accordance with Rule 457(c) and Rule 457(r) under the Securities Act of 1933, as amended. Represents payment of registration fees previously deferred in connection with the Registration Statement on Form S-3ASR (Registration No. 333-265168). |